Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00494260 · ClinicalTrials.gov registry record · Phase 2

Managing Recurrent Abdominal Pain

A Phase 2 study of Abdominal Pain, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 2
Development phase
200
Enrollment target
2
Study locations

NCT00494260: Completed Phase 2 study of Abdominal Pain, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00494260 is a Phase 2 study of Abdominal Pain that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 200 participants, above the 140-participant average among 19 other Abdominal Pain trials with a reported enrollment target (43% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00494260, a Phase 2 study of Abdominal Pain, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 2
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate the efficacy of a social learning and cognitive behavior therapy approach for treating children with Recurrent Abdominal Pain (RAP).

Conditions Studied

Interventions

  • BEHAVIORAL Social Learning and Cognitive Behavioral Therapy (SLCBT)
  • BEHAVIORAL Education Support (ES)

Study Locations (2)

New Jersey

  • Goryeb Children's Hospital/ Atlantic Health System - Morristown

Washington

  • University of Washington/ Children's Hospital and Regional Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2003-11
Est. Completion 2010-06
Phase Phase 2

What the finished NCT00494260 record still lists

NCT00494260 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 140-participant average among 19 other Abdominal Pain trials with a reported enrollment target (43% higher).

The record links to 1 condition, with Abdominal Pain appearing as the primary indexed condition, and to 2 interventions - of which Social Learning and Cognitive Behavioral Therapy (SLCBT) is the first listed.

NCT00494260 reports a single indexed study location in New Jersey, Washington.

Frequently Asked Questions

What is clinical trial NCT00494260 about?

NCT00494260 is a clinical study titled "Managing Recurrent Abdominal Pain". The purpose of this study is to evaluate the efficacy of a social learning and cognitive behavior therapy approach for treating children with Recurrent Abdominal Pain (RAP).

What is the current status of trial NCT00494260?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2003-11. Estimated completion is 2010-06.

What conditions does trial NCT00494260 study?

This clinical trial studies the following conditions: Abdominal Pain.

What interventions are being tested in trial NCT00494260?

The interventions under investigation include: Social Learning and Cognitive Behavioral Therapy (SLCBT) (BEHAVIORAL), Education Support (ES) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00494260?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00494260 being conducted?

This trial has 2 study locations across New Jersey, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00494260's enrollment target sits among peer trials

200 5th of 19 higher than 15 of 19 other Abdominal Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Abdominal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00494260, the US trial registry maintained by the National Library of Medicine. NCT00494260 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.